Quidel | QDEL - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.07B 252M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bruker USD 6.05B 77.8M 2026-06
Cerus USD 221.86M 6.67M 2025-12
Charles River Laboratories USD 7.53B 198.16M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Haemonetics USD 2.4B 94.96M 2026-03
Illumina USD 6.65B 91M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Merit Medical Systems USD 2.86B 144.34M 2026-06
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Neogen USD 3.35B 13M 2026-03
OraSure Technologies USD 379.17M 24M 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Revvity USD 12.05B 49.24M 2026-06
STAAR Surgical USD 451.12M 560K 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Waters USD 24.75B 220M 2026-06